Oral antiviral pills from Merck & Co (MRK.N) and Pfizer Inc (PFE.N) have been shown to significantly blunt the worst outcomes of COVID-19 if taken early enough, but doctors warn vaccine hesitant people not to confuse the benef..
France's public health authority has recommended people under 30 be given Pfizer's (PFE.N) Comirnaty COVID-19 vaccine when available instead of Moderna Inc's (MRNA.O) Spikevax jab, which carried comparatively higher ri..
Regeneron Pharmaceuticals Inc (REGN.O) said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in a late-stage trial, in the two to eight months period following the drug's administration...
Why not? After all, progressive lenses save you from the hassle of switching between three pairs of eyeglasses. All thanks, to the multiple focal points that make sure you have corrected vision. No matter whether you wish to look at a far off object,..
Britain will start to roll out Merck's (MRK.N) molnupiravir COVID-19 antiviral pill through a drug trial later this month, Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency said on Sunday. Last week Britain became..
British scientists have identified a version of a gene that may be associated with double the risk of lung failure from COVID-19, a finding that provides new insights into why some people are more susceptible than othersto severe illness and which op..
Pfizer Inc's (PFE.N) experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said on Friday, as its CEO vowed to make this promising new weapon in..
Europe is once again "at the epicentre" of the Covid pandemic, the World Health Organization (WHO) has warned, as cases soar across the continent. At a press conference WHO Europe head Hans Kluge said the continent could see half a milli..
Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc (MRK.N) and Ridgeback Biotherapeutics, in a boost to the fight again..